DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Chiorean EG et al.
Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101.
Oncologist 2012;
17 (01) e13-e26
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.